RADIATION PHYSICS AND CHEMISTRY, published by Pergamon-Elsevier Science Ltd in the United Kingdom, stands as a leading journal in the field of radiation studies, bridging fundamental research and practical applications. With an impressive 2023 Scopus Rank of 11 out of 58 in the Radiation category, reflecting an 81st percentile ranking, the journal maintains a robust reputation within the scientific community. The journal focuses on the experimental and theoretical aspects of radiation physics, chemistry, and their interdisciplinary applications, providing critical insights that aid the advancement of knowledge in various domains, including nuclear energy, materials science, and healthcare. Although open access options are not available, the journal garners substantial readership and engagement from researchers, professionals, and students alike, as it publishes innovative studies and reviews from 1985 through to its anticipated conclusion in 2025. The ISSN for the journal is 0969-806X, with the E-ISSN being 1879-0895, ensuring global accessibility to cutting-edge research in radiation science.

HEALTH PHYSICS is a leading academic journal dedicated to the study and dissemination of knowledge in the fields of radiology, epidemiology, and health toxicology. Published by Lippincott Williams & Wilkins, this esteemed journal has been a cornerstone of research since its inception in 1958, and it continues to foster important discussions and advancements in the discipline. With a notable impact factor and consistently ranking in the Q2 and Q3 quartiles across various categories in 2023, HEALTH PHYSICS serves as a vital resource for scholars, practitioners, and students seeking the latest insights and methodologies in the management of radiation exposure and its health implications. While the journal does not offer open access, it remains a critical platform for peer-reviewed articles that contribute to public health and environmental safety. The journal's comprehensive scope and historical significance underscore its importance in advancing knowledge and practices within its field, making it an essential read for anyone engaged in the multidisciplinary realms of health physics.

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, published by Taylor & Francis Ltd, has established itself as a premier forum for the dissemination of innovative research related to radiation biology, covering emerging topics that are crucial within the fields of radiology, nuclear medicine, and ultrasound technology. With an ISSN of 0955-3002 and an E-ISSN of 1362-3095, this journal spans over six decades, from its inception in 1959 to 2024, reflecting a rich history of scholarly contribution and a dynamic approach to addressing current challenges in the discipline. Its reputation is highlighted by its Q2 rankings in both Radiology, Nuclear Medicine and Imaging and Radiological and Ultrasound Technology for 2023, underscoring its relevance in a competitive academic landscape, with Scopus rankings placing it in the top tier of its category. While operating under a traditional access model, the journal aims to connect researchers, professionals, and students, facilitating the advancement of knowledge and fostering a deeper understanding of the impact of radiation in various medical applications. The journal plays an essential role in shaping future research directions and enhancing clinical practices globally.

Medical Dosimetry is a distinguished journal published by Elsevier Science Inc, dedicated to the advancing field of medical dosimetry and its applications within oncology, radiology, and nuclear medicine. With its ISSN 0958-3947 and E-ISSN 1873-4022, this journal serves as a crucial resource for researchers and professionals aiming to enhance their understanding of radiation treatment planning and dosage calculations. Encompassing a comprehensive range of topics from clinical dosimetry to technology assessment, Medical Dosimetry has been disseminating significant findings since its establishment in 1988, contributing to the continuous development of best practices in patient care and safety. The journal currently holds a Q3 ranking in various categories, reflecting its pivotal role in the research community, while not currently offering open access, it remains an essential reference for scholars advancing the techniques utilized in medical imaging and treatment. By fostering a platform for high-quality research, it aims to bridge the gap between theoretical studies and clinical applications, making it a vital addition to any medical library.

RADIOPROTECTION, published by EDP SCIENCES S A, stands as a pivotal journal in the multidisciplinary fields of Nuclear Energy, Public Health, and Environmental Safety. With an ISSN of 0033-8451 and an E-ISSN of 1769-700X, this journal delves into the crucial aspects of radiation protection and its interactions with health and environment, providing a platform for researchers and professionals to disseminate their findings and insights. Despite being classified in the Q4 quartile for Health, Toxicology and Mutagenesis in 2023, its Q3 status in prestigious categories such as Nuclear Energy and Engineering, and Public Health, underscores its relevance in contemporary academic discourse. The journal continues to expand its cachet with converged years of publication from 1977 to 1981 and 1988 to 2024, ensuring a rich history of scholarly contributions. Access options for interested readers include traditional subscriptions, allowing for comprehensive engagement with a broad range of topics surrounding safety, sustainability, and risk management. Whether you are a researcher, professional, or student, RADIOPROTECTION serves as an essential resource for expanding understanding and fostering innovation within its field.

The Japanese Journal of Radiology, published by SPRINGER, serves as a premier platform for disseminating cutting-edge research and clinical advancements in the fields of radiology, nuclear medicine, and imaging. With an ISSN of 1867-1071 and E-ISSN 1867-108X, this journal has established itself as a vital resource for practitioners, researchers, and students alike. Renowned for its high-quality peer-reviewed articles, it currently enjoys a respectable impact factor within the Q2 category of Scopus rankings, placing it in the 69th percentile among 333 journals in its field. The journal has seen consistent convergence of research from 2009 to 2024, further underscoring its commitment to advancing the understanding of radiological practices. Importantly, the journal offers Open Access options to facilitate widespread dissemination of knowledge, ensuring that vital research reaches its audience without barriers. Addressed in Japan, the Japanese Journal of Radiology plays a critical role in enhancing the global discourse on medical imaging, making it an essential resource for anyone engaged in this dynamic field.

Applied Radiation and Isotopes is a premier journal dedicated to the dissemination of high-quality research in the fields of radiation and isotopes, published by PERGAMON-ELSEVIER SCIENCE LTD. With a commendable impact factor reflecting its respected standing, this journal ranks in the Q3 category within Radiation according to the 2023 evaluation, emphasizing its relevance in the scientific community. Operating out of the United Kingdom, it has been a crucial platform for innovation and knowledge sharing since its inception, covering a wide array of applications ranging from the medical to the industrial sectors. Researchers can access a wealth of articles through its online platform, although it currently does not offer open access options. Applied Radiation and Isotopes is thus an essential resource for researchers, professionals, and students aiming to stay abreast of the latest developments in radiation physics and isotopic applications, making impactful contributions to the field.

Current Radiopharmaceuticals, published by Bentham Science Publishers Ltd, is an esteemed journal dedicated to advancing the field of radiopharmaceuticals. With an ISSN of 1874-4710 and an E-ISSN of 1874-4729, this journal has been a significant platform for researchers since its inception in 2009, and will continue to contribute to the literature until at least 2024. Current Radiopharmaceuticals is recognized for its impactful contributions, holding a record of Q3 in Pharmacology and Q2 in Radiology, Nuclear Medicine, and Imaging as of 2023, illustrating its vital role in these domains. The journal aims to provide a comprehensive overview of the latest techniques, applications, and innovations within the field of radiopharmaceutical science, catering to a diverse audience of researchers, professionals, and students. Despite its significant contributions, the journal remains committed to enriching the academic community with high-quality, peer-reviewed articles that can be accessed worldwide, reflecting a dedication to open dialogue and knowledge dissemination in radiopharmaceutical research.

Journal of Radiation Research and Applied Sciences, published by ELSEVIER, is a premier open-access journal since 2013, dedicated to advancing the understanding and application of radiation research in various fields. With an ISSN of 1687-8507, this journal serves as a vital resource for researchers, professionals, and students engaged in the study of the physical and biological effects of radiation, radiation physics, and its applications in medicine and industry. Its rigorous peer-review process ensures the dissemination of high-quality research that meets the growing demands for innovative solutions in radiation science. By offering comprehensive access options, the journal promotes an inclusive approach to sharing knowledge with the global community. The Journal of Radiation Research and Applied Sciences stands out as a key platform for scholarly communication, fostering advancements that impact both theory and practice in the rapidly evolving landscape of radiation research.

Radiation Oncology is a premier scholarly journal published by BMC, dedicated to advancing the field of oncology through innovative research and comprehensive reviews since its inception in 2005. With its Open Access model, the journal ensures that the latest findings in radiotherapy and cancer treatment are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and healthcare professionals. The journal has garnered an impressive reputation with prestigious rankings, achieving Q1 status in Radiology, Nuclear Medicine and Imaging and Q2 in Oncology as of 2023, reflecting its significant impact on the scientific community. In the Scopus rankings, it stands proud at Rank #61 in Radiology, Nuclear Medicine and Imaging, placing it in the top 81st percentile, and Rank #112 in Oncology at the 72nd percentile. With a converged publication plan extending through 2024, Radiation Oncology remains a vital resource for those dedicated to enhancing cancer treatment methodologies and outcomes.